Zevra Therapeutics's total assets for Q2 2025 were $256.28M, an increase of 48.39% from the previous quarter. ZVRA total liabilities were $139.05M for the fiscal quarter, a 5.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.